Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/18/1999CA2301883A1 Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2301643A1 6,9-bridged erythromycin derivatives
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/18/1999CA2244325A1 Novel amps
03/18/1999CA2244323A1 Novel gapdh
03/18/1999CA2244241A1 Novel phoh
03/17/1999EP0902087A2 Histidine kinase
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0902036A1 Peptide containing an arginine mimetic for the treatment of osteoporosis, their production, and drugs containing these compounds
03/17/1999EP0902027A1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them
03/17/1999EP0902025A2 Benzothiophenes for treatment of estrogen related conditions
03/17/1999EP0902022A1 Novel benzofuranone derivatives and process for producing the same
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0902007A1 Chalcone derivatives and drugs containing the same
03/17/1999EP0902003A1 Novel tetralone or benzopyranone derivatives and process for producing the same
03/17/1999EP0902002A1 New derivatives of phthalaldehyde, process for their preparation and their use
03/17/1999EP0901790A1 Use od moxonidine for the Treatment of neuropathic pain
03/17/1999EP0901789A1 Method of treating tourette's syndrome
03/17/1999EP0901788A2 Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament
03/17/1999EP0901786A2 Solid pharmaceutical dispersions with enhanced bioavailability
03/17/1999EP0901755A2 Cholesterol oxide adsorbing agent and processes for its production and use
03/17/1999EP0901530A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/17/1999EP0901521A1 Antigenic modulation of cells
03/17/1999EP0901503A1 Synthetic glucagon binding proteins
03/17/1999EP0901499A1 Adenosine derivatives
03/17/1999EP0901493A1 Process for the preparation of an indacene compound
03/17/1999EP0901492A1 Taxane derivatives, the preparation thereof and formulations containing them
03/17/1999EP0901489A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901488A1 2,4-diaminopyrimidine derivatives
03/17/1999EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
03/17/1999EP0901484A1 Substituted 1, 3-benzodioxoles
03/17/1999EP0901483A2 Benzofurans and benzopyrans as chronobiological agents
03/17/1999EP0901482A1 Benzofuran carboxamides and their therapeutic use
03/17/1999EP0901476A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
03/17/1999EP0901474A1 Aryl pyrimidine derivatives
03/17/1999EP0901473A1 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds
03/17/1999EP0901471A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0901469A1 Arylalkylpiperazine compounds as antioxidants
03/17/1999EP0901466A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
03/17/1999EP0901465A1 Compounds with anti-inflammatory and immunosuppressive activities
03/17/1999EP0901464A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0901462A1 Bi-aromatic compounds, compositions containing them and uses
03/17/1999EP0901459A1 Calcilytic compounds
03/17/1999EP0901379A2 Type-2 chemokine binding proteins and methods of use therefor
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901377A1 Acne treatment
03/17/1999EP0901376A1 Malatonin in combination with analgesics
03/17/1999EP0901375A1 Dhea combination therapy
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0901373A1 Alpha v Beta 3 ANTAGONISTS
03/17/1999EP0901372A1 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations
03/17/1999EP0901371A1 Alteration of microbial populations in the gastrointestinal tract
03/17/1999EP0901370A1 Stimulation of immune response with low doses of il-2
03/17/1999EP0901368A1 Dermal penetration enhancers and drug delivery systems involving same
03/17/1999EP0901367A1 Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and textile fibre materials
03/17/1999EP0819003A4 A method for the treatment of macular degeneration
03/17/1999EP0799231B1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0786946B1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
03/17/1999EP0737070A4 Vitamin d 3? analogues and pathway to mediate disorders
03/17/1999EP0724591B1 Delta 16 unsaturated c 17 heterocyclic steroids useful as steroid c 17-20 lyase inhibitors
03/17/1999EP0708774B1 IMIDAZO[1,2-a]PYRAZIN-4-ONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
03/17/1999EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
03/17/1999EP0673249B1 Triazoloquinazolines for the treatment of diseases of the central nervous system
03/17/1999EP0661975B1 Transdermal treatment of urticaria USING OPTICALLY PURE (+) CETIRIZINE
03/17/1999EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
03/17/1999EP0637245B1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
03/17/1999EP0626954B1 Benzocycloheptenes, benzoxepines and benzothiepines
03/17/1999EP0619817B1 Novel pharmaceutically active flavilium compounds
03/17/1999EP0618806B1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
03/17/1999EP0593562B1 Topical composition containing penciclovir
03/17/1999EP0583439B1 Antimalarial synergistic compositions containing benflumetol
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211321A Methods for measurment and treatment predicated on presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
03/17/1999CN1211280A Thrombin muteins as antidotes for thrombin inhibitors
03/17/1999CN1211256A 17-beta-cyclopropyl (amino/oxy 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and C17-20-lyase
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211252A Coralyne analogs as topoisomerase inhibitors
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211242A Biologically active benzothiazolone ethananines
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211232A Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
03/17/1999CN1211194A Implantable acrylamide copolymer hydrogel for therapeutic uses
03/17/1999CN1211193A Contraceptive release systems with antibacterial and/or antiviral effect
03/17/1999CN1211192A Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
03/17/1999CN1211191A Gel formulations containing growth factors
03/17/1999CN1211186A Method of treating otitis media with uridine triphosphates and related compounds
03/17/1999CN1211185A Sulfate conjugates of ursodeoxychloric acid, and their beneficial use in inflammatory disorders and other applications
03/17/1999CN1211184A Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents
03/17/1999CN1211183A Methods for preparation of biphenyl isoxazole sulfonamides
03/17/1999CN1211182A Neovascularization inhibitor
03/17/1999CN1211181A Use of pyruvate for retarding neutrophil infiltratration and morphologic loss in ischemic bowel
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
1 ... 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 ... 7860